SHANGHAI, March 6, 2024/PRNewswire/ -- Genting Xinyao (HKEX 1952.HK), a biopharmaceutical company focused on the development, manufacture and commercialization of innovative drugs and vaccines, announced today that the company will announce its 2023 annual results and business progress on March 28, 2024, Beijing time, and hold an online performance conference in English and Chinese on the same day.

The English session will be held on March 28, 2024 at 9:00 a.m. Beijing time (March 27 at 9:00 p.m. EST); the Chinese session will be held at 11:00 a.m. Beijing time on the same day (March 27 at 11:00 p.m. EST).

Participants can join the conference in English and Chinese through the following links:

English conference:

Meeting time:Thursday, March 28, 2024, 9:00 a.m. (Beijing time)

Early registration link：

Live conference link:

At the same time, participants can also dial into the conference call using the following dial-in information:

Conference in Chinese:

Meeting time:Thursday, March 28, 2024, 11:00 a.m. (Beijing time)

Live conference link:

At the same time, participants can also dial into the conference call using the following dial-in information:

After the English conference is over, you can listen to the English conference replay by visiting Genting Xinyao's official website ().

About Genting Xinyao

Genting Xinyao is a biopharmaceutical company focusing on the development, manufacture and commercialization of innovative drugs and vaccines. It is committed to meeting the unmet medical needs of the Asian market. Genting Xinyao's management team has carried out high-quality clinical development, pharmaceutical administration affairs, chemical manufacturing and control (CMC), business development and operation in leading pharmaceutical companies in China and the world, and has deep expertise and rich experience. Genting Xinyao has created pioneering or best-in-class drug combinations for various diseases, including nephrology diseases, infectious and infectious diseases, and autoimmune diseases. For more information, visit the company website:.

Forward-looking statements:

The information published in this press release may include certain forward-looking statements, which are based on the Company's or management's current views, beliefs, and current expectations regarding the Company's business operations and financial situation, and may use “will,” “anticipation,” “expectation,” “intention,” “plan,” “believe,” “estimate,” “confidence,” and other similar terms. These forward-looking statements are not a guarantee of future results and are subject to risk, uncertainty and other factors. Some are beyond our control and difficult to predict. Therefore, actual results may differ significantly from the information contained in the forward-looking statements due to various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company and its subsidiaries, directors, managers, advisors and agents have not and do not assume any obligation to update the forward-looking statements contained in this publication to reflect the latest information, future projects or circumstances after the date of publication of this press release, unless required by law.